The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Interest Expense : BDT Mil (TTM As of . 20)

View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. The IBN SINA Pharmaceutical Industry's interest expense for the six months ended in . 20 was BDT 0.00 Mil. The IBN SINA Pharmaceutical Industry does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. The IBN SINA Pharmaceutical Industry's Operating Income for the six months ended in . 20 was BDT 0.00 Mil. The IBN SINA Pharmaceutical Industry's Interest Expense for the six months ended in . 20 was BDT 0.00 Mil. The IBN SINA Pharmaceutical Industry did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

The IBN SINA Pharmaceutical Industry Interest Expense Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry Interest Expense Chart

The IBN SINA Pharmaceutical Industry Annual Data

Trend

Interest Expense

The IBN SINA Pharmaceutical Industry Semi-Annual Data

Interest Expense

The IBN SINA Pharmaceutical Industry Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

The IBN SINA Pharmaceutical Industry's Interest Expense for the six months ended in . 20 was BDT0.00 Mil. Its Operating Income for the six months ended in . 20 was BDT0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was BDT0.00 Mil.

The IBN SINA Pharmaceutical Industry's Interest Coverage for the quarter that ended in . 20 is calculated as

The IBN SINA Pharmaceutical Industry had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207

Website

https://www.ibnsinapharma.com

The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Headlines

No Headlines